Patents by Inventor Lan Jiang

Lan Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
    Publication number: 20090036483
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: September 22, 2008
    Publication date: February 5, 2009
    Inventors: Adam A. Goldblum, Seok-ki Choi, Paul R. Fatheree, Roland Gendron, Lan Jiang, Daniel D. Long, Daniel Marquess, S. Derek Turner
  • Rechargeable bipolar high power electrochemical device with reduced monitoring requirement
    Patent number: 7476463
    Abstract: The present invention is drawn to a high power electrochemical energy storage device in a bipolar configuration, comprising at least n stackable cells in bipolar configuration wherein subgroups of m cells are electronically monitored. The storage cells have a lithium ion insertion anode and a lithium ion insertion cathode, a separator, an electrolyte system, and a leak-proof seal structure. A number of embodiments are disclosed, characterized by a favorable range of m values, in combination with the anode-to-cathode capacity ratio, electrolyte conductivity, and other battery key features, thereby providing a high power device providing long cycle life and excellent power performance over many thousand charge and discharge cycles while minimizing the cost for electronic monitoring.
    Type: Grant
    Filed: August 16, 2004
    Date of Patent: January 13, 2009
    Assignee: Pacific Lithium New Zealand Limited
    Inventors: Hans Desilvestro, Casey Ann Van Veen, Nancy Lan Jiang, Brett Ammundsen
  • Quinolinone compounds as 5-HTreceptor agonists
    Patent number: 7446114
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: November 4, 2008
    Assignee: Theravance, Inc.
    Inventors: Adam A. Goldblum, Seok-ki Choi, Paul R. Fatheree, Roland Gendron, Lan Jiang, Daniel D. Long, Daniel Marquess, S. Derek Turner
  • 5-HT4 RECEPTOR AGONIST COMPOUNDS
    Publication number: 20080255187
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: June 11, 2008
    Publication date: October 16, 2008
    Inventors: Seok-Ki Choi, Paul Fatheree, Adam A. Goldblum, Lan Jiang, Daniel D. Long, Daniel Marquess, S. Derek Turner
  • 5-HTreceptor agonist compounds
    Patent number: 7399862
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: November 4, 2005
    Date of Patent: July 15, 2008
    Assignee: Theravance, Inc.
    Inventors: Seok-Ki Choi, Paul Fatheree, Adam A Goldblum, Lan Jiang, Daniel D Long, Daniel Marquess, S. Derek Turner
  • Quinolinone-carboxamide compounds
    Publication number: 20080167295
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: March 13, 2008
    Publication date: July 10, 2008
    Inventors: Seok-Ki Choi, Paul Fatheree, Roland Gendron, Adam A. Goldblum, Lan Jiang, Daniel D. Long, Daniel Marquess
  • Quinolinone-carboxamide compounds
    Patent number: 7396933
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: November 4, 2005
    Date of Patent: July 8, 2008
    Assignee: Theravance, Inc.
    Inventors: Seok-Ki Choi, Paul Fatheree, Roland Gendron, Adam A Goldblum, Lan Jiang, Daniel D Long, Daniel Marquess
  • 8-Azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
    Publication number: 20070219278
    Abstract: The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I): wherein R1, R2, R3, A, and G are defined in the specification, or a pharmaceutically-acceptable salt or solvate thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: February 28, 2007
    Publication date: September 20, 2007
    Inventors: Daniel D. Long, Timothy J. Church, John R. Jacobsen, Lan Jiang, Daisuke Roland Saito, Ioanna Stergiades, Priscilla M. Van Dyke, Sean Dalziel, Leticia Maria Preza
  • Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
    Publication number: 20060270652
    Abstract: The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I) wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: May 24, 2006
    Publication date: November 30, 2006
    Inventors: Robert McKinnell, Roland Gendron, Lan Jiang, Seok-ki Choi, Daniel Long, Paul Fatheree, Daniel Marquess
  • Quinolinone compounds as 5-HT4 receptor agonists
    Publication number: 20060199839
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: March 1, 2006
    Publication date: September 7, 2006
    Inventors: Adam Goldblum, Seok-ki Choi, Paul Fatheree, Roland Gendron, Lan Jiang, Daniel Long, Daniel Marquess, S. Turner
  • Quinolinone-carboxamide compounds
    Publication number: 20060100426
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: November 4, 2005
    Publication date: May 11, 2006
    Inventors: Seok-Ki Choi, Paul Fatheree, Roland Gendron, Adam Goldblum, Lan Jiang, Daniel Long, Daniel Marquess
  • 5-HT4 receptor agonist compounds
    Publication number: 20060100236
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: November 4, 2005
    Publication date: May 11, 2006
    Applicant: THERAVANCE, INC.
    Inventors: Seok-Ki Choi, Paul Fatheree, Adam Goldblum, Lan Jiang, Daniel Long, Daniel Marquess, S. Turner
  • Lactone integrin antagonists
    Patent number: 6906051
    Abstract: The present invention relates to a class of compounds represented by the Formula I: or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the ?V?3 and/or the ?V?5 integrin.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: June 14, 2005
    Assignee: Pharmacia Corporation
    Inventors: Peter Ruminiski, Thomas D. Penning, Lan Jiang, Balekudru Devadas, Thomas Rogers, Jennifer VanCamp, Chester Yuan
  • Lactone integrin antagonists
    Publication number: 20040116472
    Abstract: The present invention relates to a class of compounds represented by the Formula I.
    Type: Application
    Filed: November 19, 2003
    Publication date: June 17, 2004
    Applicant: Pharmacia Corporation
    Inventors: Peter Ruminiski, Thomas D. Penning, Lan Jiang, Balekudru Devadas, Thomas Rogers, Jennifer VanCamp, Chester Yuan
  • Lactone integrin antagonists
    Patent number: 6720327
    Abstract: The present invention relates to a class of compounds represented by the Formula I. or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the &agr;v&bgr;3 and/or the &agr;v&bgr;5 integrin.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: April 13, 2004
    Assignee: Pharmacia Corporation
    Inventors: Peter Ruminski, Thomas D. Penning, Lan Jiang, Balekudru Devadas, Thomas Rogers, Jennifer VanCamp, Chester Yuan
  • Hydroxy acid integrin antagonists
    Publication number: 20040024062
    Abstract: The present invention relates to compounds, pharmaceutical compositions and method of using &agr;v&bgr;3 and/or &agr;v&bgr;5 selective integrin antagonists.
    Type: Application
    Filed: March 27, 2003
    Publication date: February 5, 2004
    Inventors: Thomas Rogers, Thomas D. Penning, Lan Jiang, Balekudru Devadas, Peter Ruminiski, Jennifer VanCamp, Chester Yuan
  • Lactone integrin antagonists
    Publication number: 20040019206
    Abstract: The present invention relates to compounds, pharmaceutical compositions and method of using &agr;v&bgr;3 and/or &agr;v&bgr;5 selective integrin antagonists.
    Type: Application
    Filed: March 27, 2003
    Publication date: January 29, 2004
    Inventors: Peter Ruminiski, Thomas D Penning, Lan Jiang, Balekudru Devadas, Thomas Rogers, Jennifer VanCamp, Chester Yuan
  • Hydroxy acid integrin antagonists
    Publication number: 20020072500
    Abstract: The present invention relates to a class of compounds represented by the Formula I.
    Type: Application
    Filed: September 26, 2001
    Publication date: June 13, 2002
    Inventors: Thomas Rogers, Thomas D. Penning, Lan Jiang, Balekudru Devadas, Peter Ruminiski, Jennifer VanCamp, Chester Yuan
  • Lactone integrin antagonists
    Publication number: 20020045645
    Abstract: The present invention relates to a class of compounds represented by the Formula I.
    Type: Application
    Filed: September 26, 2001
    Publication date: April 18, 2002
    Inventors: Peter Ruminiski, Thomas D. Penning, Lan Jiang, Balekudru Devadas, Thomas Rogers, Jennifer VanCamp, Chester Yuan